The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart Study.
May HT, Nelson JR, Lirette ST, Kulkarni KR, Anderson JL, Griswold ME, Horne BD, Correa A, Muhlestein JB. The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart Study. Eur J Prev Cardiol. 2016 May; 23(7):769-76.